Showing results (31-40 of 438) with videos related to
Sort By:
Pageof 44
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 19, 2025
MSI-H locally recurrent rectal cancer: Immune checkpoint inhibitors vs. standard chemotherapy and pelvic exenterationLuca Sorrentino, Vincenzo Nasca, Elena Daveri, et al.Drug Safety|January 17, 2019
Safety and Tolerability of c-MET Inhibitors in CancerAlberto Puccini, Nagore I Marín-Ramos, Francesca Bergamo, et al.Clinical Colorectal Cancer|January 18, 2023
Adverse Events Associated with Encorafenib Plus Cetuximab in Patients with BRAFV600E-mutant Metastatic Colorectal Cancer: An in-depth Analysis of the BEACON CRC StudyJulien Taieb, Sara Lonardi, Jayesh Desai, et al.Frontiers in Pharmacology|April 11, 2024
Patient experience of medication administration and development of a Patient Experience and Preference Questionnaire (PEPQ) for patients with advanced or metastatic cancerAnne Skalicky, Bryan Bennett, Judith Raimbourg, et al.Expert Review of Clinical Pharmacology|May 6, 2016
Ramucirumab for the treatment of gastric cancers, colorectal adenocarcinomas, and other gastrointestinal malignanciesGiuseppe Aprile, Laura Ferrari, Chiara Cremolini, et al.Cancers|April 14, 2026
DNA Methylation in Gastric Cancer and Preneoplastic Lesions: Emerging Insights and Future DirectionsCarlotta Ceccon, Giulia Maddalena, Valentina Angerilli, et al.Expert Review of Anticancer Therapy|January 18, 2018
The role of tumor angiogenesis as a therapeutic target in colorectal cancerFrancesca Battaglin, Alberto Puccini, Rossana Intini, et al.Aging|June 14, 2019
Immune senescence and immune activation in elderly colorectal cancer patientsSilvia Giunco, Maria Raffaella Petrara, Francesca Bergamo, et al.Future Oncology (London, England)|January 19, 2021
Appropriateness of trifluridine/tipiracil in the clinical practice of third-line therapy in metastatic colorectal cancerCarlo Barone, Maria Di Bartolomeo, Sara Lonardi, et al.International Journal of Surgical Pathology|August 17, 2019
Pathological Tumor Regression Grade Classifications in Gastrointestinal Cancers: Role on Patients' PrognosisGiuseppe N Fanelli, Fotios Loupakis, Elizabeth Smyth, et al.Pageof 44